Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

Market Cap	6.15B +0.3%
Revenue (ttm)	1.48B +5.0%
Net Income	224.77M +8.1%
EPS	0.27 +7.2%
Shares Out	828.87M
PE Ratio	27.10
Forward PE	n/a
Dividend	0.09 (1.21%)
Ex-Dividend Date	May 29, 2026

Volume	38,385,248
Open	7.89
Previous Close	7.35
Day's Range	7.05 - 7.89
52-Week Range	5.99 - 9.59
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SHE:002349

Jinghua Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers active pharmaceutical ingredients (APIs) and intermediates, chemical and pharmaceutical intermediates, Chinese medicinal herbs and materials, health products, and Western medicine products. It also provides Jidesheng antivenomous tablets, Nantong Wang’s baby health pill, Ningning ZhengChaihu granules, Dachaihu granules, Gubenkechuan tablets, dizzine...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 1,462
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002349

Financial Performance

In 2025, SHE:002349's revenue was 1.46 billion, an increase of 4.13% compared to the previous year's 1.40 billion. Earnings were 219.28 million, an increase of 3.12%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error